Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NanoViricides, Inc. Common Stock (NY: NNVC )

1.190 -0.010 (-0.83%)
Official Closing Price Updated: 8:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NanoViricides, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
62 Biggest Movers From Yesterday
Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced... 
Via Benzinga
COVID-19 Variants: What the Future Could Look Like After the Pandemic
Photo by Martin Sanchez on Unsplash Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will... 
Via Benzinga
Exposures COVID-19
54 Biggest Movers From Yesterday
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon... 
Via Benzinga
Nanomedicine Company Makes "Nanomachines" that Attack Viruses
Photo by Fusion Medical Animation on Unsplash Ever since scientists discovered the existence of viruses in the late 1800s, virologists have tried to understand and prevent them... 
Via Benzinga
45 Biggest Movers From Yesterday
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First... 
Via Benzinga
Nanomedicine Company Makes "Nanomachines" that Attack Viruses
Photo by Fusion Medical Animation on Unsplash Ever since scientists discovered the existence of viruses in the late 1800s, virologists have tried to understand and prevent them... 
Via Benzinga
NanoViricides Review: What you Need to Know About the Company
With the coronavirus changing the world in 2020, it makes sense that there’s a spotlight on science to prevent viruses from growing into pandemics. While Pfizer (NYSE: PFE)... 
Via Benzinga
Exposures COVID-19
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND
SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel... 
From NanoViricides, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Product Safety
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.